Coyle Financial Counsel’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$825K Sell
713
-27
-4% -$31.9K 0.15% 49
2026
Q2
$887K Buy
740
+154
+26% +$157K 0.16% 53
2026
Q1
$539K Buy
586
+104
+22% +$105K 0.11% 61
2025
Q4
$518K Buy
482
+189
+65% +$181K 0.11% 63
2025
Q3
$224K Buy
293
+10
+4% +$7.44K 0.05% 93
2025
Q2
$221K Buy
+283
New +$220K 0.06% 84
2018
Q3
– Sell
-3,660
Closed -$312K – 182
2018
Q2
$312K Buy
+3,660
New +$301K 0.29% 43

Other funds holding LLY

Coyle Financial Counsel's LLY Position: Q3 2026 in Review

Coyle Financial Counsel reduced its Eli Lilly (LLY) stake by 3.6% in Q3 2026, selling an estimated $31.9K and leaving 713 shares worth $825K. The position accounts for 0.15% of the portfolio, ranked #49.

Coyle Financial Counsel first reported a position in LLY in Q2 2018 and has held it in 7 quarters since. The position peaked at $887K in Q2 2026. 4,106 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Coyle Financial Counsel held 713 shares of Eli Lilly worth $825K as of Q3 2026.
  • Coyle Financial Counsel sold 27 Eli Lilly shares in Q3 2026, an estimated $31.9K.
  • Eli Lilly made up 0.15% of Coyle Financial Counsel's portfolio in Q3 2026, its #49 holding.
  • Coyle Financial Counsel first reported a position in Eli Lilly in Q2 2018 and has held it in 7 quarters since.
  • Coyle Financial Counsel's Eli Lilly position peaked at $887K in Q2 2026.
  • 4,106 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Coyle Financial Counsel's 13F filing for Q3 2026, filed 28 Oct 2026.